Allergopharma plans to invest € 40 million in production facility

16-Dec-2013 - Germany

Merck broke ground on a new production facility for its Allergopharma unit in Reinbek near Hamburg. The new facility, which is estimated to cost nearly € 40 million, will be used, among other things, to expand production to serve new markets such as China. In the two-story building, which will be constructed on the current Allergopharma premises, products for the diagnosis and treatment of type 1 allergies such as hay fever or allergic asthma are to be manufactured under ultrapure, sterile conditions. Completion of the building is scheduled for 2016.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances